PRMT5 and cancer: Similar to the observations regarding alterations in SHARPIN expression in cancer (Figure 1A), the expression level of PRMT5 was also found to be dramatically elevated in both human lung adenocarcinoma and squamous cell carcinoma compared with that in normal lung samples by analysis of RNA-sequencing from TCGA (Figure 3A).